Kupffer cell blockade improves the endotoxin-induced microcirculatory inflammatory response in obstructive jaundice. 2008

Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
Department of Surgery, University of Szeged, Szeged, Hungary.

Cholestasis predisposes to hypersensitivity to LPS, leading to potential septic complications. We set out to characterize the involvement of Kupffer cell (KC) activation in the hepatic microcirculatory and structural consequences of obstructive jaundice in the presence and absence of acute endotoxemia. The hepatic microcirculatory consequences of 3-day extrahepatic bile duct ligation (BDL) were assessed in rats. The contributions of changes in hepatic perfusion, leukocyte influx, and proinflammatory cytokine release to the development of hepatic structural damage were also determined. Furthermore, the corresponding consequences of BDL in combination with acute (2-h) endotoxemia (1 mg kg(-1) LPS, i.v.) were compared with those observed after LPS alone. In a second series, the same protocols were applied in identical groups of rats where the KC function was inhibited with 24-h gadolinium chloride pretreatment (10 mg kg(-1), i.v.). Bile duct ligation induced minor inflammatory reactions but caused a marked reduction in hepatic sinusoidal perfusion and severe histological damage. LPS treatment, however, elicited an approximately 5-fold increase in leukocyte adherence in the central venules and pronounced IL-6 and TNF-alpha release, but without significant structural damage. The combination of BDL with LPS enhanced the perfusion failure, leukocyte sticking/deposition, and proinflammatory cytokine release; most of these changes can be effectively ameliorated by gadolinium chloride. In conclusion, when obstructive jaundice is followed by a second hit of LPS, perfusion failure, liver inflammation, and structural damage are enhanced, the KCs playing a decisive role in this scenario. Therapeutic strategies aimed at KC blockade can potentially reduce the risk of inflammatory complications in cholestasis.

UI MeSH Term Description Entries
D007728 Kupffer Cells Specialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood and dispose of worn out red blood cells. Kupffer Cell,Cell, Kupffer,Cells, Kupffer
D008026 Ligation Application of a ligature to tie a vessel or strangulate a part. Ligature,Ligations,Ligatures
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D005682 Gadolinium An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001652 Bile Ducts The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage. Bile Duct,Duct, Bile,Ducts, Bile
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
May 1999, The British journal of surgery,
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
October 2002, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
August 1986, Surgery,
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
December 1995, Archives of surgery (Chicago, Ill. : 1960),
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
June 1996, Gut,
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
March 1988, Archives of surgery (Chicago, Ill. : 1960),
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
March 1983, Recenti progressi in medicina,
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
January 2013, International journal of surgery (London, England),
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
December 1998, The Journal of surgical research,
Szabolcs Abrahám, and Andrea Szabó, and József Kaszaki, and Renáta Varga, and Katalin Eder, and Erno Duda, and György Lázár, and László Tiszlavicz, and Mihály Boros, and György Lázár
February 1993, Archives of surgery (Chicago, Ill. : 1960),
Copied contents to your clipboard!